APA (7th ed.) Citation

KM, I. (2012). Preclinical antiepileptic actions of selective serotonin reuptake inhibitors--implications for clinical trial design. Epilepsia, 53(4), 596. https://doi.org/10.1111/j.1528-1167.2012.03427.x

Chicago Style (17th ed.) Citation

KM, Igelström. "Preclinical Antiepileptic Actions of Selective Serotonin Reuptake Inhibitors--implications for Clinical Trial Design." Epilepsia 53, no. 4 (2012): 596. https://doi.org/10.1111/j.1528-1167.2012.03427.x.

MLA (9th ed.) Citation

KM, Igelström. "Preclinical Antiepileptic Actions of Selective Serotonin Reuptake Inhibitors--implications for Clinical Trial Design." Epilepsia, vol. 53, no. 4, 2012, p. 596, https://doi.org/10.1111/j.1528-1167.2012.03427.x.